Trial Profile
Phase II trial of Apatinib in patients with recurrence or metastasis of malignant tumors of the thymus after failure of platinum chemotherapy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- 30 Oct 2017 New trial record